ICON plc-a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries-announced it has acquired the patient-centered health outcomes research and commercialization company, Mapi Group.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!